Depression is a complex and disabling psychiatric disorder, which is expected to be a leading cause for disability by 2030. According to World Health Organization, about 350 million people are suffering with mental health disorders around the globe, especially depression. However, the mechanisms involved in stress-induced depression have not been fully elucidated. In this study, a stress-like state was pharmacologically induced in zebrafish using reserpine, a drug widely used to mediate depression in experimental animal models. Zebrafish received single intraperitoneal (i.p.) injections of 20, 40, and 80 mg/kg body weight reserpine doses and were subjected to open-field test at 2, 24, 48, 72, and 96 h after the treatment. Along with observed changes in behavior and measurement of cortisol levels, the fish were further examined for perturbations in their brain metabolites by 1H nuclear magnetic resonance (NMR)-based metabolomics. We found a significant increase in freezing duration, whereas total distance travelled was decreased 24 h after single intraperitoneal injection of reserpine. Cortisol level was also found to be higher after 48 h of reserpine treatment. The 1H NMR data showed that the levels of metabolites such as glutamate, glutamine, histamine, valine, leucine and histidine, lactate, l-fucose, betaine and γ-amino butyric acid (GABA), β-hydroxyisovalerate, and glutathione were significantly decreased in the reserpine-treated group. This study provided some insights into the molecular nature of stress that could contribute toward a better understanding of depression disorder.
Get full access to this article
View all access options for this article.
References
1.
AkimotoH, OshimaS, OharaK, NegishiA, HiroyamaH, NemotoT, et al.Metabolic profiling of hippocampal tissue in rats with depression-like symptoms. Biol Pharm Bull, 2018; 40:789–796.
2.
ChisholmD, SweenyK, SheehanP, RasmussenB, SmitF, CuijpersP, et al.Scaling-up treatment of depression and anxiety: a global. Lancet Psychiatry, 2016; 3:415–424.
3.
NeumannID, WegenerG, HombergJR, CohenH, SlatteryDA, ZoharJ, et al.Animal models of depression and anxiety: what do they tell us about human condition?. Prog Neuropsychopharmacol Biol Psychiatry, 2011; 35:1357–1375.
4.
GoldPW. The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry, 2014; 20:1–16.
5.
van PraagHM. Can stress cause depression?. World J Biol Psychiatry, 2005; 6(Suppl 2): 5–22.
6.
MiltonHA, WernerF, OttoK. Pharmacology of reserpine and its implications for anesthesia. Anesthesiology, 1963; 24:524–542.
7.
PereiraAG, PoliA, Matheus FCLB, daSilva, FadanniGP, IzídioGS, et al.Temporal development of neurochemical and cognitive impairments following reserpine administration in rats. Behav Brain Res, 2020; 383:1–7.
8.
NguyenM, StewartAM, KalueffAV. Aquatic blues: modeling depression and antidepressant action in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry, 2014; 55:26–39.
9.
HoweK, ClarkMD, TorrojaCF, TorranceJ, BerthelotC, MuffatoM, et al.The zebrafish reference genome sequence and its relationship to the human genome. Nature, 2013; 496:498–503.
10.
FulcherN, TranS, ShamsS, ChatterjeeD, GerlaiR. Neurochemical and behavioral responses to unpredictable chronic mild stress following developmental isolation: the zebrafish as a model for major depression. Zebrafish, 2017; 14:23–24.
11.
KyzarE, StewartAM, LandsmanS, CollinsC, GebhardtM, RobinsonK, et al.Behavioral effects of bidirectional modulators of brain monoamines, reserpine and d-amphetamine in zebrafish. Brain Res, 2013; 1527:108–116.
12.
SaroyaR, SmithR, SeymourC, MothersillC. Injection of resperpine into zebrafish, prevents fish to fish communication of radiation-induced bystander signals: confirmation in vivo of a role for serotonin in the mechanism. Dose Response, 2010; 8:317–330.
13.
YalkowskySH: Aqueous Solubility Data. CRC Press, Taylor and Francis Group, Boca Raton, FL, 2010.
14.
NeelyMN, PfeiferJD, CaparonM. Streptococcus-zebrafish model of bacterial pathogenesis. Infect Immun, 2002; 70:3904–3914.
15.
PhelpsHA, RunftDL, NeelyMN. Adult zebrafish model of streptococcal infection. Curr Protoc Microbiol, 2009; 13:Chapter 9, Unit 9D.1.
16.
RichettiSK, BlankM, CapiottiKM, PiatoAL, BogoMR, ViannaMR, et al.Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav Brain Res, 2011; 217:10–15.
17.
BorvinskayaE, GurkovA, ShchapovaE, BaduevB, MeglinskiI, TimofeyevM. Distribution of PEG-coated hollow polyelectrolyte microcapsules after introduction into the circulatory system and muscles of zebrafish. Biol Open, 2018; 7:1–12.
18.
WilsonJM, BunteRM, CartyAJ. Evaluation of rapid cooling and tricaine methanesulfonate (MS222) as methods of euthanasia in zebrafish (Danio rerio). J Am Assoc Lab Anim Sci, 2009; 48:785–789.
19.
WongRY, OxendineSE, GodwinJ. Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment. BMC Genomics, 2013; 14:1–13.
20.
YoonC, YoonD, ChoJ, KimS, LeeH, ChoiH, et al.1H NMR-based metabolomics studies of bisphenol A in zebrafish (Danio rerio). J Environ Sci Health B, 2017; 52:282–289.
21.
PittmanJ, HyltonA. Behavioral, endocrine, and neuronal alterations in zebrafish (Danio rerio) following sub-chronic coadministration of fluoxetine and ketamine. Biochem Behav Part B, 2015; 139:158–162.
22.
CachatJ, StewartA, GrossmanL, GaikwadS, KadriF, ChungKM, et al.Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc, 2010; 5:1786–1799.
23.
RamboCL, MocelinR, MarconM, VillanovaD, KoakoskiG, de AbreuMS, et al.Gender differences in aggression and cortisol levels in zebrafish subjected to unpredictable chronic stress. Physiol Behav, 2017; 171:50–54.
24.
ReolonGK, de MeloGM, da RosaJGS, BarcellosLJG, BonanCD. Sex and the housing: effects on behavior, cortisol levels and weight in zebrafish. Behav Brain Res, 2018; 336:85–92.
25.
de AbreuMS, GiacominiACVV, GenarioR, dos SantosBE, MarconL, DeminKA, et al.The impact of housing environment color on zebrafish anxiety-like behavioral and physiological (cortisol) responses. General and Comparative Endocrinology, 2020; 294:113499.
26.
GuptaT, MullinsMC. Dissection of organs from the adult zebrafish. J Vis Exp, 2010; 37:1–5.
27.
LiuJ, Ann SheldonR, SegalMR, KellyMJS, PeltonJG, FerrieroDM, et al.1H nuclear magnetic resonance brain metabolomics in neonatal mice after hypoxia–ischemia distinguished normothermic recovery from mild hypothermia recoveries. Pediatr Res, 2013; 74:170–179.
28.
QiaoR, ShengC, LuY, ZhangY, RenH, LemosB. Microplastics induce intestinal inflammation, oxidative stress, and disorders of metabolome and microbiome in zebrafish. Sci Total Environ, 2019; 662:246–253
BeckonertO, KeunHC, EbbelsTMD, BundyJ, HolmesE, LindonJC, et al.Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc, 2007; 2:2692–2703.
31.
WishartDS, TzurD, KnoxC, EisnerR, GuoAC, YoungN, et al.HMDB: the Human Metabolome Database. Nucleic Acids Res, 2007; 35:521–526.
32.
BelleauEL, TreadwayMT, PizzagalliDA. The impact of stress and major depressive disorder on hippocampal and median prefrontal cortex morphology. Biol Psychiatry, 2019; 85:443–453.
33.
da Silva BrumE, FialhoMFP, FischerSPM, HartmannDD, GonçalvesDF, ScusselR, et al.Relevance of mitochondrial dysfunction in the reserpine-induced experimental fibromyalgia model. Mol Neurobiol, 2020; 57:4202–4217.
34.
KalueffAV, TuohimaaP. Experimental modeling of anxiety and depression. Acta Neurobiol Exp, 2004; 64:439–448.
35.
DumanCH. Models of depression. Vitam Horm, 2010; 82:1–21.
36.
AbelairaHM, RéusGZ, QuevedoJ. Animal models as tools to study the pathophysiology of depression. Braz J Psychiatry, 2013; 35:112–120.
37.
StewartAM, CachatJ, GaikwadS, RobinsonKS, GebhardtM, KalueffAV. Perspectives on experimental models of serotonin syndrome in zebrafish. Neurochem Int, 2013; 62:893–902.
38.
AldermanSL, BernierNJ. Ontogeny of the corticotropin-releasing factor system in zebrafish. Gen Comp Endocrinol, 2009; 164:610–669.
39.
AlsopD, VijayanMM. Development of the corticosteroid stress axis and receptor expression in zebrafish. Am J Physiol Regul Integr Comp Physiol, 2008; 294:711–719.
40.
RamsayaJM, FeistaGW, VargabZM, WesterfieldbM, KentdML, SchreckCB. Whole-body cortisol response of zebrafish to acute net handling stress. Aquaculture, 2009; 297:157–162.
41.
PavlidisM, TheodoridiA, TsalafoutaA. Neuroendocrine regulaton of the stress response in adult zebrafish, Danio rerio. Prog Neuropsychopharmacol Biol Psychiatry, 2015; 60:121–131.
42.
QuinonesMP, Kaddurah-DaoukR. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis, 2009; 35:165–176.
43.
JohnsonCH, IvanisevicJ, SiuzdakG. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cel Biol, 2016; 17:451–459.
44.
ShiB, TianJ, XiangH, GuoX, ZhangL. A 1H-NMR plasma metabonomic study of acute and chronic stress models of depression in rats. Behav Brain Res, 2013; 241:86–91.
45.
LiuX, ZhengP, ZhaoX, ZhangY, HuC, LiJ, et al.Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry. J Proteome Res, 2015; 14:2322–2330.
46.
ZhengP, WangY, ChenL, YangD, MengH, ZhouD, et al.Identification and validation of urinary metabolite biomarkers for major depressive disorder. Mol Cell Proteomics, 2013; 12:207–214.
47.
ZhangR. Metabolomic profiling of post-mortem brain reveals changes in amino acid and glucose metabolism in mental illness compared with controls. Comput Struct Biotechnol J, 2016; 14:106–116.
48.
ZhouX, LiuL, ZhangY, PuJ, YangL, ZhouC, et al.Metabolomics identifies perturbations in amino acid metabolism in the prefrontal cortex of the learned helplessness rat model of depression. Neuroscience, 2016; 343:1–9.
49.
WooHI, ChunMR, YangJS, LimSW, KimMJ, KimSW, et al.Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors. CNS Neurosci Ther, 2015; 21:417–424.
50.
YoshikawaT, NakamuraT, ShibakusaT, SugitaM, NaganumaF, IidaT, et al.Insufficient intake of l-histidine reduces brain histamine and causes anxiety-like behaviors in male mice. J Nutr, 2014; 144:1637–1641.
51.
BestJ. A mathematical model for histamine synthesis, release, and control in varicosities. Theor Biol Med Model, 2017; 14:1–19.
52.
ShanL, BaoA, SwaabDF. The human histaminergic system in neuropsychiatric disorders. Trends Neurosci, 2015; 38:167–177.
53.
MunariL. Brain histamine is crucial for selective serotonin reuptake inhibitors' behavioral and neurochemical effects. Int J Neuropsychopharmacol, 2015; 18:1–10.
54.
KanoM, FukudoS, TashiroA, UtsumiA, TamuraD, ItohM, et al.Decreased histamine H1 receptor binding in the brain of depressed patients. Eur J Neurosci, 2004; 20:803–810.
55.
DuH, ZhangH, ZhaoY, LiuM, ChenA, LiuS, et al.Metabolic analysis of the antidepressive effects of Yangxinshi Tablet in a vascular depression model in mice. Biomed Chromatogr, 2017; 32:1–9.
56.
RileyCA, RenshawPF. Brain choline in major depression: a review of the literature. Psychiatry Res Neuroimaging, 2018; 271:142–153.
57.
AlbiñanaE, LuengoJG, BaraibarAM, MuñozMD, GandíaL. Choline induces opposite changes in pyramidal neuron excitability and synaptic transmission through a nicotinic receptor-independent process in hippocampal slices. Pflugers Arch, 2017; 469:779–795.
58.
Diego-AdeliñoJ, de PortellaMJ, Gómez-AnsónB, López-MorueloO, Serra-BlascoM, VivesY, et al.Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden. Biol Psychiatry Cogn Neurosci Neuroimaging, 2013; 38:107–116.
59.
BrunoD, NierenbergJ, CooperTB, MarmarCR, ZetterbergH, BlennowK, et al.Neurobiology of learning and memory: the recency ratio is associated with reduced CSF glutamate in late-life depression. Neurobiol Learn Mem, 2017; 141:14–18.
60.
NiciuMJ, IonescuDF, RichardsEM, ZarateC. Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm (Vienna), 2013; 121:907–924.
61.
WangW, GuoH, ZhangSX, LiJ, ChengK, BaiSJ, et al.Targeted metabolomic pathway analysis and validation revealed glutamatergic disorder in the prefrontal cortex among chronic social defeat stress mice model of depression. J Proteome Res, 2016; 15:3784–3792.
62.
HashimotoK, BrunoD, NierenbergJ, MarmarCR, ZetterbergH, BlennowK, et al.Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study. Transl Psychiatry, 2016; 6:744–746.
63.
RamadanS, LinA. Glutamate and glutamine: a review of in vivo MRS in the human brain. NMR Biomed, 2014; 26:1–36.
64.
ChenG, YangD, YangY, LiJ, ChengK, TangG, et al.Amino acid metabolic dysfunction revealed in the prefrontal cortex of a rat model of depression. Behav Brain Res, 2015; 278:286–292.
65.
DetkaJ, KurekA, KucharczykM, GłombikK, Basta-KaimA, KuberaM, et al.Brain glucose metabolism in an animal model of depression. Neuroscience, 2015; 295:198–208.
ChenJ, ZhouCJ, ZhengP, ChengK, WangHY, LiJ, et al.Differential urinary metabolites related with the severity of major depressive disorder. Behav Brain Res, 2017; 332:280–287.
68.
SzczesniakO, HestadKA, HanssenJF, RudiK. Isovaleric acid in stool correlates with human depression. Nutr Neurosci, 2016; 19:279–283.
69.
MichelsN, WieleVD, HenauwS. Chronic psychosocial stress and gut health in children: associations with calprotectin and fecal short-chain fatty acids. Psychosom Med, 2017; 9:927–935.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
